Question

--/1 Question 6 View Policies Current Attempt in Progress Amy Dyken, controller at Grouper Pharmaceutical Industries, a publi

0 0
Add a comment Improve this question Transcribed image text
Answer #1

Page - No 9 Anacoren. @ Basic coringa po na share Nebe income = $ 15.20,000 Preferred dividend = $50 pan value x(67.X26500) =Page No ③ Interest on convertide bonds nels off tax = (-20%) x 8 % X5080,000 = 0.8 %0.08 X 5080/000 $325120 areighted average- Page No ③ 1440500 + 305120 990,000 + 254000 + 55000 1765620 1299000 = $ 1136 per share : . Diluted carinings por sharic - $

Add a comment
Know the answer?
Add Answer to:
--/1 Question 6 View Policies Current Attempt in Progress Amy Dyken, controller at Grouper Pharmaceutical Industries,...
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for? Ask your own homework help question. Our experts will answer your question WITHIN MINUTES for Free.
Similar Homework Help Questions
  • Question 6 --/1 View Policies Current Attempt in Progress Amy Dyken, controller at Teal Pharmaceutical Industries,...

    Question 6 --/1 View Policies Current Attempt in Progress Amy Dyken, controller at Teal Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Teal's financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Teal Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt Notes payable, 9% 7% convertible bonds payable 9% bonds payable $1,010,000 5,070,000 6,120,000 $12.200.000 Total long-term...

  • Amy Dyken, controller at Wildhorse Pharmaceutical Industries, a public company, is currently preparing the calculation for...

    Amy Dyken, controller at Wildhorse Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Wildhorse’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Wildhorse Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt    Notes payable, 11% $1,020,000    9% convertible bonds payable 5,020,000    11% bonds payable 6,120,000      Total long-term debt $12,160,000 Shareholders’ equity    Preferred stock, 5% cumulative, $50 par...

  • Amy Dyken, controller at Wildhorse Pharmaceutical Industries, a public company, is currently preparing the calculation for...

    Amy Dyken, controller at Wildhorse Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Wildhorse’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Wildhorse Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt    Notes payable, 10% $1,020,000    9% convertible bonds payable 4,970,000    10% bonds payable 5,980,000      Total long-term debt $11,970,000 Shareholders’ equity    Preferred stock, 5% cumulative, $50 par...

  • Amy Dyken, controller at Sunland Pharmaceutical Industries, a public company, is currently preparing the calculation for...

    Amy Dyken, controller at Sunland Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Sunland's financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Sunland Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt Notes payable, 10% 9% convertible bonds payable 10% bonds payable Total long-term debt $990,000 5,040,000 6,080,000 $12,110,000 Shareholders' equity Preferred stock, 5% cumulative, $50 par...

  • Amy Dyken, controller at Bridgeport Pharmaceutical Industries, a public company, is currently preparing the calculation for...

    Amy Dyken, controller at Bridgeport Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Bridgeport’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Bridgeport Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt    Notes payable, 10% $990,000    9% convertible bonds payable 5,040,000    10% bonds payable 6,080,000      Total long-term debt $12,110,000 Shareholders’ equity    Preferred stock, 5% cumulative, $50 par...

  • Amy Dyken, controller at Sunland Pharmaceutical Industries, a public company, is currently preparing the calculation for...

    Amy Dyken, controller at Sunland Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Sunland's financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Sunland Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt Notes payable, 10% 9% convertible bonds payable 10% bonds payable Total long-term debt $990,000 5,040,000 6,080,000 $12,110,000 Shareholders' equity Preferred stock, 5% cumulative, $50 par...

  • 16.2 #3 PLEASE SHOW ALL WORK Amy Dyken, controller at Swifty Pharmaceutical Industries, a public company,...

    16.2 #3 PLEASE SHOW ALL WORK Amy Dyken, controller at Swifty Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Swifty's financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Swifty Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt Notes payable, 10% 9% convertible bonds payable 10% bonds payable Total long-term debt $1,010,000 5,090,000 6,060,000 $12,160,000 Shareholders' equity...

  • Amy Dyken, controller at Blossom Pharmaceutical Industries, a public company, is currently preparing the calculation for...

    Amy Dyken, controller at Blossom Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Blossom’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Blossom Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt    Notes payable, 10% $1,020,000    8% convertible bonds payable 5,080,000    10% bonds payable 6,110,000      Total long-term debt $12,210,000 Shareholders’ equity    Preferred stock, 6% cumulative, $50 par...

  • Amy Dyken, controller at Waterway Pharmaceutical Industries, a public company, is currently preparing the calculation for...

    Amy Dyken, controller at Waterway Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Waterway’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Waterway Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt Notes payable, 10% $1,020,000 8% convertible bonds payable 5,080,000 10% bonds payable 6,110,000 Total long-term debt $12,210,000 Shareholders’ equity Preferred stock, 6% cumulative, $50 par...

  • Amy Dyken, controller at Sandhill Pharmaceutical Industries, a public company, is currently preparing the calculation for...

    Amy Dyken, controller at Sandhill Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Sandhill’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Sandhill Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt    Notes payable, 10% $1,010,000    9% convertible bonds payable 5,030,000    10% bonds payable 5,990,000      Total long-term debt $12,030,000 Shareholders’ equity    Preferred stock, 6% cumulative, $50 par...

ADVERTISEMENT
Free Homework Help App
Download From Google Play
Scan Your Homework
to Get Instant Free Answers
Need Online Homework Help?
Ask a Question
Get Answers For Free
Most questions answered within 3 hours.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT